NOAEL Studies
Cosmetic Ingredient
Bis(Butylbenzoate) Diaminotriazine Aminopropyltrisiloxane NOAEL Studies
INCI: BIS(BUTYLBENZOATE) DIAMINOTRIAZINE AMINOPROPYLTRISILOXANE
CAS: 207562-42-3
Raw No Observed Adverse Effect Level endpoint records grouped by source. This page does not render calculated Margin of Safety values.
SCCS Opinion 9 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| SCCS Opinion | NOAEL | =1 | % | human | oral | - | NOAEL study | p.28 |
| SCCS Opinion | NOAEL | =1.34 | mg/kg bw/day | rat | oral | 13 week | NOAEL study | p.29 |
| SCCS Opinion | NOAEL | =3.3 | - | human | oral | - | NOAEL study | p.28 |
| SCCS Opinion | NOAEL | =4.46 | % | human | oral | - | NOAEL study | p.29 |
| SCCS Opinion | NOAEL | =8 | - | human | oral | - | NOAEL study | p.28 |
| SCCS Opinion | NOAEL | =10 | - | - | oral | 10 months | NOAEL study | p.25 |
| SCCS Opinion | NOAEL | =100 | % | rat | oral | 13 week | NOAEL study | p.29 |
| SCCS Opinion | NOAEL | =1000 | mg/kg bw/day | rat | oral | Sub-chronic | repeated dose toxicity | p.17 |
| SCCS Opinion | NOAEL | =1000 | mg/kg bw/d | - | oral | 28 day | genotoxicity | p.18 |
Regulatory source 16 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| Regulatory source | - | 1 | % | human | oral | - | - | p.28 |
| Regulatory source | - | 1.34 | mg/kg bw/day | rat | oral | 13 week | - | p.29 |
| Regulatory source | - | 3.3 | - | human | oral | - | - | p.28 |
| Regulatory source | - | =4.46 | % | human | oral | - | - | p.29 |
| Regulatory source | - | 8 | - | human | oral | - | - | p.28 |
| Regulatory source | - | 10 | - | - | oral | 10 months | - | p.25 |
| Regulatory source | - | 10 | % | - | oral | 90-day | - | p.31 |
| Regulatory source | - | 100 | % | rat | oral | 13 week | - | p.29 |
| Regulatory source | - | 1000 | mg/kg bw/d | - | oral | - | - | p.28 |
| Regulatory source | - | 1000 | mg/kg bw/d | - | oral | 90 day | - | p.28 |
| Regulatory source | - | =1000 | mg/kg bw/d | rat | oral | 13 week | - | p.29 |
| Regulatory source | developmental toxicity | 1000 | mg/kg bw/day | - | - | developmental | developmental toxicity | p.24 |
| Regulatory source | genotoxicity | 1000 | mg/kg bw/d | - | oral | 28 day | genotoxicity | p.18 |
| Regulatory source | genotoxicity | 1000 | mg/kg bw/d | mouse | oral | 4 week | genotoxicity | p.30 |
| Regulatory source | repeated dose toxicity | 1000 | mg/kg bw/day | rat | oral | Sub-chronic | repeated dose toxicity | p.17 |
| Regulatory source | reproductive toxicity | 1000 | mg/kg bw/d | - | oral | 90 day | reproductive toxicity | p.31 |
openFDA substances 1 endpoint
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| openFDA substances | FDA UNII substance identifier | 50I65NU3DV | UNII | - | - | - | chemical | - |